The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Edgewise Therapeutics Inc shares valued at $10,000,000 were purchased by Thompson Peter A. on Apr 03 ’25. At $20.13 per share, Thompson Peter A. acquired 496,771 shares. The insider’s holdings grew to 14,809,075 shares worth approximately $242.87 million following the completion of this transaction.
Also, ORBIMED ADVISORS LLC purchased 496,771 shares, netting a total of over 10,000,000 in proceeds. Following the buying of shares at $20.13 each, the insider now holds 14,809,075 shares.
Before that, Russell Alan J had sold 200 shares from its account. In a trade valued at $6,004, the Chief Scientific Officer traded Edgewise Therapeutics Inc shares for $30.02 each. Upon closing the transaction, the insider’s holdings decreased to 200 shares, worth approximately $0.24 million.
As published in their initiating research note from Guggenheim on April 30, 2025, Edgewise Therapeutics Inc [EWTX] has been a Buy and the price target has been revised to $41. Analysts at Scotiabank downgraded the stock from ‘”a Sector outperform”‘ to ‘”a Sector perform”‘ outlook in a report released in early April. As of March 07, 2025, Scotiabank has initiated its “Sector outperform” rating for EWTX. Earlier on January 22, 2025, Stifel initiated its rating. Their recommendation was “a Hold” for EWTX stock.
Analyzing EWTX Stock Performance
During the last five days, there has been a surge of approximately 10.59%. Over the course of the year, Edgewise Therapeutics Inc shares have dropped approximately -38.58%. Shares of the company reached a 52-week high of $30.48 on 02/06/25 and a 52-week low of $10.60 on 04/07/25. A 50-day SMA is recorded $20.52, while a 200-day SMA reached $24.95.
Support And Resistance Levels for Edgewise Therapeutics Inc (EWTX)
According to the 24-hour chart, there is a support level at 15.36, which, if violated, would cause prices to drop to 14.31. In the upper region, resistance lies at 16.99. The next price resistance is at 17.58. RSI (Relative Strength Index) is 49.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.97, which suggests the price will increase in the coming days. Percent R is at 2.64%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
